We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
251
DELISTED
Discover Financial Services
DFS
| $44M | 0.1% |
454,293
-1,575
| -0.3% | -$158K |
|
252
Aon
AON
$75.7B
| $43.9M | 0.1% |
146,194
-13,453
| -8% | -$3.93M |
|
253
NorthWestern Energy
NWE
$4.38B
| $43.7M | 0.1% |
736,693
-26,894
| -4% | -$1.47M |
|
254
Ulta Beauty
ULTA
$23.6B
| $43.7M | 0.1% |
93,832
-58,606
| -38% | -$25.3M |
|
255
Fidelity National Information Services
FIS
$21.9B
| $43.5M | 0.1% |
647,241
+334,516
| +107% | +$23.8M |
|
256
Skyworks Solutions
SWKS
$10.4B
| $42.7M | 0.1% |
474,982
+188,777
| +66% | +$16.9M |
|
257
DTE Energy
DTE
$28.5B
| $42.7M | 0.1% |
363,247
-112,562
| -24% | -$12.8M |
|
258
First American
FAF
$7.37B
| $42.5M | 0.1% |
813,595
-129,759
| -14% | -$6.57M |
|
259
Reinsurance Group of America
RGA
$15.8B
| $42.4M | 0.1% |
298,242
+65,042
| +28% | +$9.08M |
|
260
Honeywell
HON
$77B
| $42.2M | 0.1% |
209,897
+2,041
| +1% | +$390K |
|
261
MSC Industrial Direct
MSM
$6.87B
| $42.2M | 0.1% |
519,273
-27,431
| -5% | -$2.24M |
|
262
SLB Ltd
SLB
$78.9B
| $42.1M | 0.1% |
798,718
-597,378
| -43% | -$29.7M |
|
263
Jefferies Financial Group
JEF
$12.8B
| $41.9M | 0.1% |
1,291,313
-175,092
| -12% | -$5.82M |
|
264
Vale
VALE
$63.4B
| $41.6M | 0.09% |
2,453,082
-2,515,216
| -51% | -$37.8M |
|
265
Grand Canyon Education
LOPE
$3.82B
| $41.6M | 0.09% |
393,604
-21,872
| -5% | -$2.18M |
|
266
Labcorp
LH
$26.1B
| $41.5M | 0.09% |
205,347
-50,980
| -20% | -$9.96M |
|
267
eBay
EBAY
$47.9B
| $41.4M | 0.09% |
1,000,835
+371,269
| +59% | +$15.4M |
|
268
Exelixis
EXEL
$13.1B
| $41.2M | 0.09% |
2,626,603
+924,500
| +54% | +$15.1M |
|
269
FirstEnergy
FE
$27.1B
| $41.2M | 0.09% |
981,588
-562,048
| -36% | -$22M |
|
270
NVR
NVR
$16.8B
| $41M | 0.09% |
8,929
-1,425
| -14% | -$6.26M |
|
271
Ovintiv
OVV
$17.6B
| $41M | 0.09% |
807,928
+62,765
| +8% | +$3.28M |
|
272
NVIDIA
NVDA
$5.27T
| $40.9M | 0.09% |
2,835,610
-1,965,720
| -41% | -$28.8M |
|
273
XPO
XPO
$23.5B
| $40.9M | 0.09% |
1,227,906
-240,128
| -16% | -$8.09M |
|
274
Align Technology
ALGN
$12.5B
| $40.9M | 0.09% |
194,346
+123,671
| +175% | +$24.8M |
|
275
Simon Property Group
SPG
$71.5B
| $40.8M | 0.09% |
350,783
-462,232
| -57% | -$51.4M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.